Pharma's Obesity Campaigns Juggle Awareness And Advertising. Pharma giants are bankrolling obesity awareness campaigns ...

Doctors say the biggest risk factors for a stroke include high blood pressure, smoking, obesity, diabetes and lack of ...

Column written by Dr Kimberley Watkins] May marks World Stroke Month – a time to raise awareness, share hope, and take action ...

Federal health officials want access to most Americans' medical records, new research links screen time to brain development, ...

Lipedema Team will headline the free, virtual 2026 Lipedema Summit, with surgeons Dr. Max Sirota and Dr. José Carlos ...

Stroke is the fourth leading cause of death in America, according to the National Institutes of Health.

Health advocates are encouraging them to establish a relationship with a primary care physician to maintain fitness and lower the ris ...

Eli Lilly has paused an obesity awareness campaign in India in response to a regulatory notice regarding advertising rules for prescription medicines, Reuters reports. In March, India’s Central Drugs ...

India's drug regulator says Lilly's ads could indirectly promote its prescription drugs Lilly cites regulatory uncertainty over non-branded, doctor-led campaigns, requests clarity India's obesity ...

Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even ...

India’s drugs regulator in an advisory sent to Eli Lilly in March said product advertisements, including surrogate promotions that may indirectly lead consumers to a medicine, are prohibited across ...

FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are placed on a table for a photograph in a health clinic in Hyderabad, India ...